Cargando…
Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss
Regulators of G protein signaling (RGS) accelerate the GTPase activity of G proteins to enable rapid termination of the signals triggered by G protein-coupled receptors (GPCRs). Activation of several GPCRs, including cannabinoid receptor 2 (CB2R) and adenosine A(1) receptor (A(1)AR), protects agains...
Autores principales: | Dhukhwa, Asmita, Al Aameri, Raheem F. H., Sheth, Sandeep, Mukherjea, Debashree, Rybak, Leonard, Ramkumar, Vickram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046767/ https://www.ncbi.nlm.nih.gov/pubmed/33854102 http://dx.doi.org/10.1038/s41598-021-87387-5 |
Ejemplares similares
-
Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss
por: Sheth, Sandeep, et al.
Publicado: (2019) -
Local Drug Delivery for Prevention of Hearing Loss
por: Rybak, Leonard P., et al.
Publicado: (2019) -
The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss
por: Ghosh, Sumana, et al.
Publicado: (2018) -
Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity
por: Ramkumar, Vickram, et al.
Publicado: (2021) -
Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea
por: Bhatta, Puspanjali, et al.
Publicado: (2019)